99 related articles for article (PubMed ID: 14692511)
1. Some 1,2-diphenylethane derivatives as inhibitors of retinoic acid--metabolising enzymes.
Greer VP; Mason P; Kirby AJ; Smith HJ; Nicholls PJ; Simons C
J Enzyme Inhib Med Chem; 2003 Oct; 18(5):431-43. PubMed ID: 14692511
[TBL] [Abstract][Full Text] [Related]
2. Some aryl substituted 2-(4-nitrophenyl)-4-oxo-4-phenylbutanoates and 3-(4-nitrophenyl)-1-phenyl-1,4-butanediols and related compounds as inhibitors of rat liver microsomal retinoic acid metabolising enzymes.
Mason P; Greer VP; Kirby AJ; Simons C; Nicholls PJ; Smith HJ
J Enzyme Inhib Med Chem; 2003 Dec; 18(6):511-28. PubMed ID: 15008516
[TBL] [Abstract][Full Text] [Related]
3. Some 3-(4-aminophenyl)pyrrolidine-2,5-diones as all-trans-retinoic acid metabolising enzyme inhibitors (RAMBAs).
Kirby AJ; Lelain R; Mason P; Maharlouie F; Nicholls PJ; Smith HJ; Simons C
J Enzyme Inhib Med Chem; 2002 Oct; 17(5):321-7. PubMed ID: 12683748
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinoic acid metabolising enzymes by 2-(4-aminophenylmethyl)-6-hydroxy-3,4-dihydronaphthalen-1(2H)-one and related compounds.
Kirby AJ; Le Lain R; Maharlouie F; Mason P; Nicholls PJ; Smith HJ; Simons C
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):27-33. PubMed ID: 12751817
[TBL] [Abstract][Full Text] [Related]
5. Effect of P450 isozyme-selective inhibitors on in-vitro metabolism of retinoic acid by rat hepatic microsomes.
Ahmad M; Nicholls PJ; Smith HJ; Ahmadi M
J Pharm Pharmacol; 2000 Mar; 52(3):311-4. PubMed ID: 10757419
[TBL] [Abstract][Full Text] [Related]
6. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole.
Vanden Bossche H; Willemsens G; Janssen PA
Skin Pharmacol; 1988; 1(3):176-85. PubMed ID: 2856164
[TBL] [Abstract][Full Text] [Related]
8. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays.
Yee SW; Jarno L; Gomaa MS; Elford C; Ooi LL; Coogan MP; McClelland R; Nicholson RI; Evans BA; Brancale A; Simons C
J Med Chem; 2005 Nov; 48(23):7123-31. PubMed ID: 16279770
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid metabolism inhibition by 3-azolylmethyl-1H-indoles and 2, 3 or 5-(alpha-azolylbenzyl)-1H-indoles.
Le Borgne M; Marchand P; Le Baut G; Ahmadi M; Smith HJ; Nicholls PJ
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):155-8. PubMed ID: 12943199
[TBL] [Abstract][Full Text] [Related]
10. Both all-trans retinoic acid and cytochrome P450 (CYP26) inhibitors affect the expression of vitamin A metabolizing enzymes and retinoid biomarkers in organotypic epidermis.
Pavez Loriè E; Chamcheu JC; Vahlquist A; Törmä H
Arch Dermatol Res; 2009 Aug; 301(7):475-85. PubMed ID: 19294396
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
Casabar RC; Wallace AD; Hodgson E; Rose RL
Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities.
Koul S; Koul JL; Taneja SC; Dhar KL; Jamwal DS; Singh K; Reen RK; Singh J
Bioorg Med Chem; 2000 Jan; 8(1):251-68. PubMed ID: 10968285
[TBL] [Abstract][Full Text] [Related]
14. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice.
Patel JB; Huynh CK; Handratta VD; Gediya LK; Brodie AM; Goloubeva OG; Clement OO; Nanne IP; Soprano DR; Njar VC
J Med Chem; 2004 Dec; 47(27):6716-29. PubMed ID: 15615521
[TBL] [Abstract][Full Text] [Related]
15. Effect of cytochromes P450 chemical inhibitors and monoclonal antibodies on human liver microsomal esterase activity.
Polsky-Fisher SL; Cao H; Lu P; Gibson CR
Drug Metab Dispos; 2006 Aug; 34(8):1361-6. PubMed ID: 16720683
[TBL] [Abstract][Full Text] [Related]
16. Functional properties and substrate characterization of human CYP26A1, CYP26B1, and CYP26C1 expressed by recombinant baculovirus in insect cells.
Helvig C; Taimi M; Cameron D; Jones G; Petkovich M
J Pharmacol Toxicol Methods; 2011; 64(3):258-63. PubMed ID: 21906690
[TBL] [Abstract][Full Text] [Related]
17. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells.
Sonneveld E; van den Brink CE; van der Leede BM; Schulkes RK; Petkovich M; van der Burg B; van der Saag PT
Cell Growth Differ; 1998 Aug; 9(8):629-37. PubMed ID: 9716180
[TBL] [Abstract][Full Text] [Related]
18. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil.
Hyland R; Roe EG; Jones BC; Smith DA
Br J Clin Pharmacol; 2001 Mar; 51(3):239-48. PubMed ID: 11298070
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone.
Baldwin SJ; Clarke SE; Chenery RJ
Br J Clin Pharmacol; 1999 Sep; 48(3):424-32. PubMed ID: 10510156
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
